HomeRLAY • NASDAQ
add
Relay Therapeutics Inc
Previous close
$9.89
Day range
$9.61 - $10.47
Year range
$1.78 - $11.43
Market cap
1.81B USD
Avg Volume
2.35M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 7.00M | — |
Operating expense | 13.59M | -33.86% |
Net income | -54.89M | 27.78% |
Net profit margin | -784.14 | — |
Earnings per share | -0.31 | 31.11% |
EBITDA | -62.33M | 25.48% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 554.52M | -29.03% |
Total assets | 621.33M | -28.69% |
Total liabilities | 54.27M | -41.96% |
Total equity | 567.06M | — |
Shares outstanding | 178.73M | — |
Price to book | 3.03 | — |
Return on assets | -24.37% | — |
Return on capital | -25.36% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -54.89M | 27.78% |
Cash from operations | -44.86M | 22.47% |
Cash from investing | 35.46M | 22.29% |
Cash from financing | 934.00K | 16.75% |
Net change in cash | -8.47M | 69.83% |
Free cash flow | -28.99M | 11.98% |
About
Founded
2015
Website
Employees
192
